WEEKEND OFFER: Subscribe For Just ₹̶2̶9̶9̶9̶ ₹699
India's Drug Regulator Approves Psoriasis Drug For Emergency Use In Covid-19 Treatment
Biocon Biologics Gets DCGI Nod For Emergency Use Of CytoSorb To Treat Critical Covid-19 Patients
Nirmala Sitharaman Responds On Twitter To Criticism By Biocon Head Kiran Mazumdar-Shaw On E-Cigarette Ban And Economy
Innovation Nation: Innovation Is Only One Of The Three Perfectly Acceptable Strategies